focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,775.00
Bid: 1,771.00
Ask: 1,771.50
Change: -8.50 (-0.48%)
Spread: 0.50 (0.028%)
Open: 1,773.50
High: 1,779.00
Low: 1,764.50
Prev. Close: 1,783.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Stocks edge higher, AB Foods jumps on Primark expansion

Wed, 23rd Apr 2014 08:40

- AB Foods jumps on Primark expansion plans- Stocks rise, but upside limited- BoE minutes, economic data ahead- Chinese manufacturing PMI contracts againtechMARK 2,749.64 +0.41%FTSE 100 6,688.65 +0.10%FTSE 250 16,067.20 -0.09%UK stocks edged higher on Wednesday morning with Primark owner Associated British Foods leading the risers as markets extended gains after a surge the day before.AB Foods' share price jumped strongly this morning after the company announced plans to open its first Primark store in the States, as it rolls out the fast-growing fashion outlet overseas.The FTSE 100 was trading 0.1% higher at 6,689 in early trading today, though upside was limited after a 0.9% gain on Tuesday on the back of heightened M&A activity and bid speculation in the global pharmaceutical sector."The gains over the last few days have seen a welcome turn around after the initial weak start to the month, but now as we edge near to the top of recent range, traders are looking hesitant in case sellers emerge again," said Dealer Jonathan Sudaria from Capital Spreadex.The mood is likely to remain cautious ahead of a host of data and macro-economic announcements during the session, including the minutes of the Bank of England meeting this morning. Figures on UK public finances, a reading on business optimism from the CBI and US housing data will be in focus today, along with any developments in the ongoing Ukraine crisis.Markets were also reacting to yet another contraction in the Chinese manufacturing sector this month. A private survey out from HSBC and Markit showed the 'flash' reading of the purchasing managers' index for Chinese manufacturing was 48.3 in April, up slightly from 48 in March but still below the key 50-point threshold that separates contraction and growth.AB Foods jumps on US expansion, resultsAB Foods was trading 9% higher after saying that it would open new Primark stores in north-east US. The chain, which already has stores in nine countries in Western Europe, has signed a lease for 70,000 square feet of selling space in Boston and will open the shop towards the end of 2015. Further stores are planned across the wider region through to the middle of 2016.The company also reported a 4% increase in adjusted pre-tax profits to £468m for the 24 weeks to March 1st, helped by a 26% jump in operating profits at Primark.Antofagasta was trading firmly in the red this morning after going ex-dividend, meaning that from today new investors won't be able to obtain the company's latest payout. FTSE 100-listed peers Aggreko, BG Group, Centrica, Legal & General, Mondi, Old Mutual and Rolls-Royce were also trading without the rights to their latest dividends this morning.A number of FTSE 250 stocks were also lower after going ex-dividend, including Hikma, Drax, Kentz and Tullett Prebon.AstraZeneca was continuing to rise on speculation that US pharmaceutical peer Pfizer could offer as much as £60bn to buy the company, representing the largest foreign takeover of a UK business on record. The stock, which rose 5% yesterday, was making solid gains this morning.Similarly, GlaxoSmithKline was extending gains after yesterday unveiling a massive three-part deal with Swiss firm Novartis, under which shareholders will receive a £4bn a capital return.Retail-focused property group Hammerson rose after giving a confident outlook, saying that an improving UK recovery filtered through to demand in the first quarter.High street sporting goods retailer Sports Direct fell after seeing a slight slowdown in growth in the fourth quarter. The company also warned of "further uncertainty" arising from its decision to cancel a controversial bonus payout to founder Mike Ashley earlier this month.FTSE 100 - RisersAssociated British Foods (ABF) 2,970.00p +9.11%AstraZeneca (AZN) 4,045.00p +2.15%Wolseley (WOS) 3,431.00p +2.08%Shire Plc (SHP) 3,195.00p +1.56%Admiral Group (ADM) 1,384.00p +1.54%Royal Mail (RMG) 529.50p +1.44%Hammerson (HMSO) 580.50p +1.13%Johnson Matthey (JMAT) 3,274.00p +1.05%Tesco (TSCO) 295.35p +1.01%GlaxoSmithKline (GSK) 1,655.00p +0.91%FTSE 100 - FallersAntofagasta (ANTO) 794.00p -5.98%Centrica (CNA) 330.00p -4.32%Morrison (Wm) Supermarkets (MRW) 197.70p -3.14%Old Mutual (OML) 197.90p -2.99%Legal & General Group (LGEN) 206.70p -2.59%ARM Holdings (ARM) 964.00p -1.93%Sports Direct International (SPD) 815.50p -1.75%Mondi (MNDI) 988.50p -1.54%Aberdeen Asset (ADN) 437.70p -1.37%Ashtead Group (AHT) 891.50p -1.00%FTSE 250 - RisersSpirent Communications (SPT) 101.60p +5.18%Thomas Cook Group (TCG) 180.00p +3.69%Perform Group (PER) 245.00p +2.94%Merlin Entertainments (MERL) 359.50p +2.07%FirstGroup (FGP) 131.00p +1.71%Polymetal International (POLY) 617.00p +1.48%SEGRO (SGRO) 349.80p +1.39%Synthomer (SYNT) 269.80p +1.28%Caledonia Investments (CLDN) 2,100.00p +1.20%Centamin (DI) (CEY) 53.50p +1.13%FTSE 250 - FallersDrax Group (DRX) 689.00p -8.92%Moneysupermarket.com Group (MONY) 179.20p -3.97%Tullett Prebon (TLPR) 300.50p -3.72%Balfour Beatty (BBY) 289.30p -3.50%Vesuvius (VSVS) 433.20p -2.65%Man Group (EMG) 100.50p -2.52%International Public Partnerships Ltd. (INPP) 126.30p -2.32%Rathbone Brothers (RAT) 1,967.00p -1.65%Laird (LRD) 286.60p -1.55%Renishaw (RSW) 1,900.00p -1.55%BC
More News
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.